Page last updated: 2024-11-04

sulfinpyrazone and Arterial Occlusive Diseases

sulfinpyrazone has been researched along with Arterial Occlusive Diseases in 14 studies

Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.

Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.

Research Excerpts

ExcerptRelevanceReference
"In patients treated with sulfinpyrazone, an apparent reduction in the incidence of sudden death and presumed ventricular fibrillation has been reported."7.66Effect of sulfinpyrazone on ventricular fibrillation during acute myocardial ischemia. ( Escobinas, AJ; Jorgensen, OB; Moschos, CB; Regan, TJ, 1981)
"In patients treated with sulfinpyrazone, an apparent reduction in the incidence of sudden death and presumed ventricular fibrillation has been reported."3.66Effect of sulfinpyrazone on ventricular fibrillation during acute myocardial ischemia. ( Escobinas, AJ; Jorgensen, OB; Moschos, CB; Regan, TJ, 1981)
" It is concluded that when initiating and withdrawing treatment with SP in a patient receiving AC, the prothrombin time should be checked daily for a few days to adapt (reduce) the dosage of AC to the change in prothrombin time induced by SP."2.65[The effect of sulfinpyrazone on the coagulation-inhibiting action of acenocoumarol]. ( Fontanilles, F; Holt, NF; Michot, F, 1981)

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-199014 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Comberg, HU1
Janssen, EJ1
Diehm, C1
Zimmermann, R1
Harenberg, J1
Walter, E1
Oster, P1
Allenberg, J1
Horsch, AK1
Mörl, H1
Cain, TD1
Wood, JS1
Beard, OW1
Michot, F1
Holt, NF1
Fontanilles, F1
Cristol, R1
Moschos, CB1
Escobinas, AJ1
Jorgensen, OB1
Regan, TJ1
Verstraete, M1
Vigdahl, RL1
Ferber, RH1
Parrish, SL1
Ostendorf, P1
Regli, F1
Michaud, PA1
Loew, D1
Genton, E1
Gent, M1
Hirsh, J1
Harker, LA2
Bollinger, A1
Di Perri, T1

Reviews

4 reviews available for sulfinpyrazone and Arterial Occlusive Diseases

ArticleYear
Medical Grand Rounds: extracranial carotid artery disease.
    The Journal of the Arkansas Medical Society, 1980, Volume: 76, Issue:1

    Topics: Adolescent; Adult; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Auscultation; Carotid Art

1980
[Platelet antiaggregants and arteriopathies].
    Journal des maladies vasculaires, 1981, Volume: 6, Issue:3

    Topics: Arterial Occlusive Diseases; Aspirin; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dipyr

1981
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (second of three parts).
    The New England journal of medicine, 1975, 12-11, Volume: 293, Issue:24

    Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Cardiac Catheterization; Clinical Tria

1975
Antiplatelet drugs in the management of patients with thrombotic disorders.
    Seminars in thrombosis and hemostasis, 1986, Volume: 12, Issue:2

    Topics: Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Blood Coagulation Disorders; Blood Platelets

1986

Trials

5 trials available for sulfinpyrazone and Arterial Occlusive Diseases

ArticleYear
[Sulfinpyrazone (Anturan) versus placebo following surgical reconstruction of the femoral artery in arterial occlusive diseases].
    VASA. Zeitschrift fur Gefasskrankheiten, 1983, Volume: 12, Issue:2

    Topics: Adult; Aged; Arterial Occlusive Diseases; Arteriosclerosis; Clinical Trials as Topic; Double-Blind M

1983
Medical Grand Rounds: extracranial carotid artery disease.
    The Journal of the Arkansas Medical Society, 1980, Volume: 76, Issue:1

    Topics: Adolescent; Adult; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Auscultation; Carotid Art

1980
[The effect of sulfinpyrazone on the coagulation-inhibiting action of acenocoumarol].
    Schweizerische medizinische Wochenschrift, 1981, Feb-21, Volume: 111, Issue:8

    Topics: Acenocoumarol; Adult; Aged; Arterial Occlusive Diseases; Blood Coagulation; Clinical Trials as Topic

1981
Internation Committee on Thrombosis and Haemostasis Basil, 8.-11. September 1974 Subcommittee on Clinical Investigations: Registry of prospective clinical trials.
    Thrombosis et diathesis haemorrhagica, 1975, Jun-30, Volume: 33, Issue:3

    Topics: Ancrod; Animals; Arterial Occlusive Diseases; Aspirin; Batroxobin; Clinical Trials as Topic; Fibrino

1975
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (second of three parts).
    The New England journal of medicine, 1975, 12-11, Volume: 293, Issue:24

    Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Cardiac Catheterization; Clinical Tria

1975

Other Studies

7 other studies available for sulfinpyrazone and Arterial Occlusive Diseases

ArticleYear
Effect of sulfinpyrazone on ventricular fibrillation during acute myocardial ischemia.
    Circulation, 1981, Volume: 64, Issue:1

    Topics: Acute Disease; Animals; Arterial Occlusive Diseases; Blood Pressure; Coronary Disease; Dogs; Electro

1981
Evaluation of antiinflammatory and antithrombotic drugs in pulmonary and arterial thrombosis.
    Thrombosis research, 1979, Volume: 16, Issue:1-2

    Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Animals; Anti-Inflammatory Agents; Arterial Occlusive Di

1979
[Therapy with anticoagulants and platelet aggregation inhibitors in extracranial vascular stenoses and occlusions].
    Der Internist, 1979, Volume: 20, Issue:11

    Topics: Anticoagulants; Arterial Occlusive Diseases; Aspirin; Cerebral Infarction; Cerebrovascular Disorders

1979
[Treatment of transient ischemic attacks (author's transl)].
    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1978, Jan-17, Volume: 67, Issue:3

    Topics: Angiography; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Endarterectomy; Humans; Ischemic

1978
[Results of clinical studies on the effect of aggregation inhibitors in arterial diseases].
    Die Medizinische Welt, 1979, Feb-02, Volume: 30, Issue:5

    Topics: Arterial Occlusive Diseases; Aspirin; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone

1979
[Secondary prevention of peripheral arterial occlusive diseases].
    Therapeutische Umschau. Revue therapeutique, 1987, Volume: 44, Issue:9

    Topics: Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Coumarins; Dipyridamole; Humans; Sulfinp

1987
[Prevention and medical treatment of polyregional vascular lesions].
    Cardiologia (Rome, Italy), 1985, Volume: 30, Issue:11

    Topics: Adult; Anticoagulants; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Diet; Dipyridamole; D

1985
chemdatabank.com